Lowila is one of the brand of Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited was established in the U.S. in 1994. RPI began marketing FDA approved generic products in the U.S. in 1998 after receiving its first FDA approval for Cefaclor, a broad spectrum anti-infective agent.